{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:46:49Z","timestamp":1792496809702,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Postinfekti\u00f6se Syndrome wie Post-COVID sind durch die COVID-19-Pandemie in den Fokus ger\u00fcckt. Das weite Spektrum von Beschwerden umfasst neben Kopf- und Gliederschmerzen, Palpitationen, Hautver\u00e4nderungen und Kurzatmigkeit auch neuropsychiatrische Symptome wie Fatigue, Ged\u00e4chtnis- und Konzentrationsst\u00f6rungen sowie Angst und affektive Symptome. Die \u00c4tiologie und Pathophysiologie der Symptome sind noch weitgehend unbekannt. Das Erleben einer schwer behandelbaren und potenziell chronischen Erkrankung stellt eine erhebliche Belastung f\u00fcr Betroffene dar, vor allem auch f\u00fcr Menschen mit psychischen Vorerkrankungen. Es ist unbedingt erforderlich, eine sorgf\u00e4ltige Abgrenzung zu anderen psychischen Erkrankungen vorzunehmen. Um Betroffene bei der Bew\u00e4ltigung der Folgen von Post-COVID ad\u00e4quat zu unterst\u00fctzen, ist psychiatrische Expertise zwingend n\u00f6tig. Dieser Artikel zeigt auf, welchen Beitrag die Psychiatrie bei der Diagnostik und Behandlung von Post-COVID leisten kann und wie sie zu einem besseren Verst\u00e4ndnis des Krankheitsbildes beitr\u00e4gt. Es werden Behandlungsans\u00e4tze und Forschungschancen diskutiert. Fachpolitische und gesellschaftliche Forderungen nach einem ganzheitlichen Ansatz, der eine interdisziplin\u00e4re Herangehensweise erfordert und sowohl klinische und wissenschaftliche Expertise als auch die Perspektive der Betroffenen miteinbezieht, werden erl\u00e4utert.<\/jats:p>","DOI":"10.1007\/s00115-026-01951-w","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:58:43Z","timestamp":1773748723000},"page":"479-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Der Stellenwert der Psychiatrie in der Versorgung und Forschung von Post-COVID","The importance of psychiatry in the care and research of Post-COVID"],"prefix":"10.1007","volume":"97","author":[{"given":"Martin","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Adorjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Bajbouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schillig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karina","family":"Schomburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schomerus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Schouler-Ocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meyer-Lindenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"1951_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/arclin\/acae042","volume":"40","author":"E Panagea","year":"2025","unstructured":"Panagea\u00a0E, Messinis\u00a0L, Petri\u00a0MC et\u00a0al (2025) Neurocognitive Impairment in Long COVID: A Systematic Review. Arch Clin Neuropsychol 40:125\u2013149","journal-title":"Arch Clin Neuropsychol"},{"key":"1951_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/cid\/ciab611","volume":"74","author":"J See\u00dfle","year":"2021","unstructured":"See\u00dfle\u00a0J, Waterboer\u00a0T, Hippchen\u00a0T et\u00a0al (2021) Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clinical Infectious Diseases 74:1191\u20131198","journal-title":"Clinical Infectious Diseases"},{"key":"1951_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/PSY.0000000000001280","volume":"86","author":"L Bobak","year":"2024","unstructured":"Bobak\u00a0L, Dorney\u00a0I, Kovacevich\u00a0A et\u00a0al (2024) Preexisting Psychiatric Conditions as Risk Factors for Diagnosed Long COVID-19 Syndrome Within Aggregated Electronic Health Record Data. Psychosom Med 86:132\u2013136","journal-title":"Psychosom Med"},{"key":"1951_CR4","series-title":"Forschungsbericht","volume-title":"COVID-19-Erkrankungen und Impfungen gegen SARS-CoV-2 bei Personen mit und Personen ohne Migrationserfahrung \u2013 Ergebnisse aus der RKI-SOEP-2\u00a0Studie","author":"LSM Go\u00dfner","year":"2023","unstructured":"Go\u00dfner\u00a0LSM (2023) COVID-19-Erkrankungen und Impfungen gegen SARS-CoV\u20112 bei Personen mit und Personen ohne Migrationserfahrung \u2013 Ergebnisse aus der RKI-SOEP-2\u00a0Studie. Forschungsbericht, vol 43. Bundesamt f\u00fcr Migration und Fl\u00fcchtlinge, N\u00fcrnberg"},{"key":"1951_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jesf.2024.06.001","volume":"22","author":"C Zheng","year":"2024","unstructured":"Zheng\u00a0C, Chen\u00a0JJ, Dai\u00a0ZH et\u00a0al (2024) Physical exercise-related manifestations of long COVID: A systematic review and meta-analysis. J\u00a0Exerc Sci Fit 22:341\u2013349","journal-title":"J Exerc Sci Fit"},{"key":"1951_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44432-3","volume":"15","author":"B Appelman","year":"2024","unstructured":"Appelman\u00a0B, Charlton\u00a0BT, Goulding\u00a0RP et\u00a0al (2024) Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun 15:17","journal-title":"Nat Commun"},{"key":"1951_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101874","volume":"58","author":"J Heine","year":"2023","unstructured":"Heine\u00a0J, Schwichtenberg\u00a0K, Hartung\u00a0TJ et\u00a0al (2023) Structural brain changes in patients with post-COVID fatigue: a prospective observational study. EClinicalMedicine 58:101874","journal-title":"EClinicalMedicine"},{"key":"1951_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf070","volume":"7","author":"L Pacheco-Jaime","year":"2025","unstructured":"Pacheco-Jaime\u00a0L, Garcia-Vicente\u00a0C, Ariza\u00a0M et\u00a0al (2025) Structural brain changes in post-COVID condition and its relationship with cognitive impairment. Brain Commun 7:fcaf070","journal-title":"Brain Commun"},{"key":"1951_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277317","volume":"17","author":"M Pantelic","year":"2022","unstructured":"Pantelic\u00a0M, Ziauddeen\u00a0N, Boyes\u00a0M et\u00a0al (2022) Long Covid stigma: Estimating burden and validating scale in a UK-based sample. PLoS One 17:e0277317","journal-title":"PLoS One"},{"key":"1951_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04335-0","volume":"23","author":"R Buchner","year":"2025","unstructured":"Buchner\u00a0R, Sander\u00a0C, Schindler\u00a0S et\u00a0al (2025) \u201cHave you considered that it could be burnout?\u201d-psychologization and stigmatization of self-reported long COVID or post-COVID-19 vaccination syndrome. BMC Med 23:488","journal-title":"BMC Med"},{"key":"1951_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10787-023-01174-4","volume":"31","author":"C Thurner","year":"2023","unstructured":"Thurner\u00a0C, Stengel\u00a0A (2023) Long-COVID syndrome: physical-mental interplay in the spotlight. Inflammopharmacology 31:559\u2013564","journal-title":"Inflammopharmacology"},{"key":"1951_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg\u00a0A, Yirmiya\u00a0R, Schuld\u00a0A et\u00a0al (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445\u2013452","journal-title":"Arch Gen Psychiatry"},{"key":"1951_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1960","volume":"11","author":"R Zefferino","year":"2021","unstructured":"Zefferino\u00a0R, Di Gioia\u00a0S, Conese\u00a0M (2021) Molecular links between endocrine, nervous and immune system during chronic stress. Brain Behav 11:e01960","journal-title":"Brain Behav"},{"key":"1951_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0889-1591(02)00004-1","volume":"16","author":"T Pollmaecher","year":"2002","unstructured":"Pollmaecher\u00a0T, Haack\u00a0M, Schuld\u00a0A et\u00a0al (2002) Low levels of circulating inflammatory cytokines--do they affect human brain functions? Brain Behav Immun 16:525\u2013532","journal-title":"Brain Behav Immun"},{"key":"1951_CR15","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1038\/s41380-021-01188-w","volume":"26","author":"Y Milaneschi","year":"2021","unstructured":"Milaneschi\u00a0Y, Kappelmann\u00a0N, Ye\u00a0Z et\u00a0al (2021) Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry 26:7393\u20137402","journal-title":"Mol Psychiatry"},{"key":"1951_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene\u00a0C, Connolly\u00a0R, Brennan\u00a0D et\u00a0al (2024) Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 27:421\u2013432","journal-title":"Nat Neurosci"},{"key":"1951_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102456","volume":"69","author":"TJ Hartung","year":"2024","unstructured":"Hartung\u00a0TJ, Bahmer\u00a0T, Chaplinskaya-Sobol\u00a0I et\u00a0al (2024) Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine 69:102456","journal-title":"eClinicalMedicine"},{"key":"1951_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55839-3","volume":"14","author":"M Reutter","year":"2024","unstructured":"Reutter\u00a0M, Hutterer\u00a0K, Grundahl\u00a0M et\u00a0al (2024) Mental health improvement after the COVID-19 pandemic in individuals with psychological distress. Sci Rep 14:5685","journal-title":"Sci Rep"},{"key":"1951_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00115-022-01306-1","volume":"93","author":"S Hellwig","year":"2022","unstructured":"Hellwig\u00a0S, Domschke\u00a0K (2022) Post-COVID syndrome-Focus fatigue. Nervenarzt 93:788\u2013796","journal-title":"Nervenarzt"},{"key":"1951_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13754","volume":"32","author":"I Merikanto","year":"2023","unstructured":"Merikanto\u00a0I, Dauvilliers\u00a0Y, Chung\u00a0F et\u00a0al (2023) Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II). J\u00a0Sleep Res 32:e13754","journal-title":"J Sleep Res"},{"key":"1951_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13949","volume":"33","author":"C Schilling","year":"2024","unstructured":"Schilling\u00a0C, Nieters\u00a0A, Schredl\u00a0M et\u00a0al (2024) Pre-existing sleep problems as a predictor of post-acute sequelae of COVID-19. J\u00a0Sleep Res 33:e13949","journal-title":"J Sleep Res"},{"key":"1951_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2025.112048","volume":"190","author":"M Schurr","year":"2025","unstructured":"Schurr\u00a0M, Graf\u00a0J, Junne\u00a0F et\u00a0al (2025) Psychotherapy in patients with long\/post-COVID - A systematic review on the feasibility, acceptability, safety, and efficacy of available and emerging interventions. J\u00a0Psychosom Res 190:112048","journal-title":"J Psychosom Res"},{"key":"1951_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/brain\/awad377","volume":"147","author":"RS McIntyre","year":"2024","unstructured":"McIntyre\u00a0RS, Phan\u00a0L, Kwan\u00a0ATH et\u00a0al (2024) Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain 147:849\u2013857","journal-title":"Brain"},{"key":"1951_CR24","unstructured":"Bundesministerium f\u00fcr Gesundheit (2024) Long COVID - Arzneimittel: Ma\u00dfnahmen zur Verbesserung der Versorgung von Long COVID-Erkrankten. https:\/\/www.bfarm.de\/DE\/Arzneimittel\/Zulassung\/Zulassungsrelevante-Themen\/Expertengruppe-Long-COVID-Off-Label-Use\/_node.html#mitglieder. Accessed 18.7.2025"},{"key":"1951_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00415-023-12069-3","volume":"271","author":"EM Martin","year":"2024","unstructured":"Martin\u00a0EM, Srowig\u00a0A, Utech\u00a0I et\u00a0al (2024) Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months. J\u00a0Neurol 271:46\u201358","journal-title":"J Neurol"},{"key":"1951_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78496-y","volume":"14","author":"AK Hennemann","year":"2024","unstructured":"Hennemann\u00a0AK, Timmermeister\u00a0M, Drick\u00a0N et\u00a0al (2024) When fatigue and cognitive impairment persist- a neurological follow-up-study in patients with Post-COVID syndrome. Sci Rep 14:27083","journal-title":"Sci Rep"},{"key":"1951_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/pcn.13789","volume":"79","author":"R Dadsena","year":"2025","unstructured":"Dadsena\u00a0R, Walders\u00a0J, Costa\u00a0AS et\u00a0al (2025) Two-year impact of COVID-19: Longitudinal MRI brain changes and neuropsychiatric trajectories. Psychiatry Clin Neurosci 79:176\u2013186","journal-title":"Psychiatry Clin Neurosci"},{"key":"1951_CR28","doi-asserted-by":"crossref","unstructured":"Wu BQ, Liu DY, Shen TC et\u00a0al. (2024) Effects of Hyperbaric Oxygen Therapy on Long COVID: A\u00a0Systematic Review. Life (Basel) 14","DOI":"10.3390\/life14040438"},{"key":"1951_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53091-3","volume":"14","author":"A Hadanny","year":"2024","unstructured":"Hadanny\u00a0A, Zilberman-Itskovich\u00a0S, Catalogna\u00a0M et\u00a0al (2024) Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial. Sci Rep 14:3604","journal-title":"Sci Rep"},{"key":"1951_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100485","volume":"24","author":"B O\u2019Kelly","year":"2022","unstructured":"O\u2019Kelly\u00a0B, Vidal\u00a0L, McHugh\u00a0T et\u00a0al (2022) Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. Brain Behav Immun Health 24:100485","journal-title":"Brain Behav Immun Health"},{"key":"1951_CR31","doi-asserted-by":"crossref","unstructured":"Markser A, Vockel J, Schneider A et\u00a0al. (2024) Non-invasive Brain Stimulation for Post-COVID-19 Conditions: A\u00a0Systematic Review. Am J Med","DOI":"10.1016\/j.amjmed.2024.07.007"},{"key":"1951_CR32","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso\u00a0MJ, Deeks\u00a0SG (2024) Mechanisms of long COVID and the path toward therapeutics. Cell 187:5500\u20135529","journal-title":"Cell"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-01951-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:51:38Z","timestamp":1788789098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-01951-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-01951-w","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Walter gibt finanzielle Unterst\u00fctzung oder Mitarbeit bei Studient\u00e4tigkeiten sowie Beratungs- und Vortragshonorare von folgenden Firmen an: Alzchem, Boehringer Ingelheim, Janssen, HEEL, HMNC, Novartis, Perception Neuroscience, Takeda. M.\u00a0Bajbouj hat Honorare f\u00fcr die Beratung und\/oder f\u00fcr Vortr\u00e4ge und\/oder f\u00fcr Lehrmaterial von Boehringer Ingelheim, Bayer und GH Research erhalten. J.\u00a0Deckert erhielt \u00f6ffentliche Drittmittelf\u00f6rderung durch NapKon-Tip und CollPan aus NUM\u00a02.0 und DFG- und BMBF- sowie Stiftungsf\u00f6rderung. C.\u00a0Schillig erh\u00e4lt derzeit Forschungsf\u00f6rderung f\u00fcr die Forschung im Bereich ME\/CFS vom BMFTR. CS erh\u00e4lt eine Verg\u00fctung f\u00fcr Referentenengagements bei der Idorsia Pharmaceuticals GmbH und f\u00fcr Lehrt\u00e4tigkeiten an psychotherapeutischen Instituten. Es gibt keine Interessenkonflikte, weder finanziell noch anderweitig, im Zusammenhang mit dieser Arbeit. K.\u00a0Adorjan, S.\u00a0K\u00f6hler, K.\u00a0Lieb, J.\u00a0Priller, A.-K.\u00a0Schomburg, G.\u00a0Schomerus, M.\u00a0Schouler-Ocak und A.\u00a0Meyer-Lindenberg geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}